Navigation Links
Internal Fixation Systems Announces 510(k) Approval Granted by FDA for Subtalar Implants

MIAMI, Jan. 23, 2012 /PRNewswire/ -- (OTC: IFIX) Internal Fixation Systems today announced that it has received 510(k) clearance from the FDA to market subtalar implants. These implants are used to preserve motion at the ankle joint and to treat both trauma conditions and arthritis.  IFS CEO, Stephen Dresnick, MD, stated that, "this approval allows us to continue to fill out our portfolio, and gives us another product for surgeons who use our products." IFS currently offers a full line of mini-cannulated screws for small bone fixation as well as a Modular Locking Small Fragment System for treatment of bone fractures and osteotomies. 

About IFS:  Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants.
We seek to prove that superior products and lower costs can go hand in hand.   IFS focuses on widely used, market proven products used to treat common fractures.  Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs.  The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition.  IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons.  Please contact us for more information about our product and business model.
This press release contains projections and forward-looking information that involve various risks and uncertainties regarding future events.  Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of Internal Fixation, such as whether we sell our new product offering  There are numerous risks and uncertainties that could cause actual results and Internal Fixation's plans and objectives to differ materially from those expressed in the forward-looking information, including whether Internal Fixation will have sufficient capital to continue its operations..  Actual results and future events could differ materially from those anticipated in such information.  These and all subsequent written and oral forward-looking information are based on estimates and views of  management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, IFS does not intend to update these forward-looking statements.For further information, please contact:

Laura Cattabriga, Chief Financial Officer


Tel: 786 268 0995



SOURCE Internal Fixation Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. JCM Passes Internal Quality Assessment for Azithromycin API Production
2. Internal and External Communication Insights: Effective Approaches for Reaching Clients and Co-Workers
3. Internal Fixation Systems, Inc. Announces Sale of Modular Locking Small Fragment System
4. Internal Fixation Systems, Inc. Announces DTC Eligibility
5. Internal Fixation Systems, Inc. Receives FDA 510(k) Clearance to Market Fixation Devices to Treat Bone Fractures and Osteotomies
6. Internal Groups are Valuable Sources for Pharmaceutical Competitive Intelligence Function
7. Building Support for a New Product Through Effective Internal Disease State Communication
8. Pharmaceutical Internal Communications Function Morphs to Address Corporate Priorities
9. Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB
10. Maximizing the Potential of Internal and External Communications Groups
11. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
Post Your Comments:
(Date:11/29/2015)... , Nov. 29, 2015 CIVCO Medical ... technology at the Radiological Society of ... Chicago November 29 – December ... designed to offer customers unrivaled versatility, enhanced user ... --> ...
(Date:11/27/2015)... -- --> --> ... potential to save costs, improve treatment quality and accelerate ... exploited as yet. Here, particular emphasis is placed on ... tablet or directly at the patients, bedside. ... -->      (Photo: ) ...
(Date:11/27/2015)... 2015 Research and Markets ( ) ... Devices Market 2015-2019" report to their offering. ... this report, the author the present scenario and growth ... To calculate the market size, the report considers revenue ... Hormonal IUDs and copper IUDs. The report forecasts the ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... ProStatic Analog Distortion ... tool designed specially for Final Cut Pro X. FCPX users can ... easy-to-use modification controls. Destoying and creating chaotic distortion is now quick and simple, ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed ... As people age, more care is needed, especially with Alzheimer’s, dementia and other ... are being overworked. The forgotten part of this equation: 80 percent of medical ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):